Can gabapentin be used to treat anxiety and symptoms of anger and irritability?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin for Anxiety, Anger, and Irritability

Gabapentin is not FDA-approved for anxiety, anger, or irritability but may be considered as an off-label treatment option in specific clinical scenarios when first-line treatments have failed or are contraindicated. 1

Efficacy and Evidence

  • Gabapentin has been used off-label for anxiety symptoms with some evidence of effectiveness, particularly in breast cancer survivors where it showed significant improvement in anxiety compared to placebo 2
  • Limited evidence exists for gabapentin's use in generalized anxiety disorder (GAD), with only case reports rather than randomized controlled trials 3
  • Gabapentin may help with symptoms of irritability and anger as part of its overall calming effect, though this is not well-studied as a primary indication 4

First-Line Treatment Options for Anxiety

  • SSRIs and SNRIs are recommended as first-line pharmacological treatments for anxiety disorders with substantial evidence supporting their efficacy 5
  • Cognitive behavioral therapy (CBT) is recommended as a first-line non-pharmacological treatment for anxiety disorders 5
  • Benzodiazepines may be used for short-term management of severe anxiety but carry risks of dependence and are not recommended for long-term use 6

Safety Concerns with Gabapentin

  • FDA labeling warns of serious side effects including:

    • Increased risk of suicidal thoughts and behaviors (approximately one additional case per 530 patients treated) 1
    • Neuropsychiatric adverse reactions, particularly in pediatric patients (3-12 years) including emotional lability, hostility, and thought disorders 1
    • Risk of physical dependence and withdrawal symptoms if stopped abruptly 1
  • Gabapentinoids (including gabapentin) have been associated with:

    • Tolerance, dependence, addiction, and withdrawal issues similar to benzodiazepines 7
    • Classification as controlled substances (Class C) in some countries due to abuse potential 7
    • Potential for misuse, though generally considered safer than many other psychotropic medications 8

Appropriate Clinical Use

  • Consider gabapentin for anxiety when:

    • First-line treatments (SSRIs, SNRIs, CBT) have failed or are contraindicated 5
    • The patient has comorbid conditions that might benefit from gabapentin (such as neuropathic pain, seizures, or insomnia) 6, 8
    • The patient has a history of substance use disorder and requires an alternative to benzodiazepines 2, 8
  • Dosing considerations:

    • Start at lower doses (300 mg daily) and titrate gradually based on response and tolerability 2
    • Higher doses (900 mg daily) may be needed for patients with more severe anxiety symptoms 2
    • Divided doses are typically used (usually 3 times daily) 1

Monitoring and Follow-up

  • Monitor for emergence of suicidal thoughts or behaviors, particularly during initial treatment or dose changes 1
  • Assess for neuropsychiatric effects including mood changes, hostility, or thought disturbances 1
  • Evaluate treatment response regularly using standardized anxiety measures when possible 6
  • Do not stop gabapentin abruptly; taper gradually to avoid withdrawal symptoms 1

Important Precautions

  • Long-term efficacy and safety data for gabapentin in anxiety disorders are lacking 7
  • Evidence for gabapentin in anxiety comes primarily from short-term studies and case reports 2, 3, 7
  • Patients should be informed that this is an off-label use not specifically approved by the FDA 1
  • Consider potential drug interactions, especially with other CNS depressants including opioids 1, 7

Conclusion

While gabapentin shows some promise for treating anxiety, anger, and irritability, it should be considered a second or third-line option after established treatments with stronger evidence bases have been tried. The decision to use gabapentin should carefully weigh potential benefits against risks of side effects and dependence.

References

Research

Treatment of Generalized Anxiety Disorder with Gabapentin.

Case reports in psychiatry, 2017

Research

Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1999

Guideline

Anxiety Disorder Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin for Substance Use Disorders: Is it Safe and Appropriate?

Journal of psychosocial nursing and mental health services, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.